在初级性综合征发病时,扩展与标准皮质类固醇治疗相比,扩展与标准皮质类固醇治疗相比
Laura Beaudoin1, Maximiliano Ferraris1, Leticia Pacheco Hernández1
1Nephrology Unit, Hospital General de Niños Pedro de Elizalde, City of Buenos Aires, Argentina.
Archivos argentinos de pediatria
|December 16, 2024
概括
与标准的8周治疗方案相比,将原发性脏综合征 (PNS) 的普德尼松治疗延长到12周并没有显著降低复发率. 两年后复发的累积发病率在两次治疗期间之间保持相似.
科学领域:
- 儿科脏病学 儿科脏病学
- 临床药理学 临床药理学
背景情况:
- 初级性综合征 (PNS) 是儿童常见的脏疾病.
- 标准治疗包括8周的普得尼松疗程.
- 建议延长治疗时间,以减少复发率.
研究的目的:
- 评估延长对初级脏综合征 (PNS) 的普德尼松治疗到12周是否会降低2年后复发的累积发病率.
- 为了比较标准和扩展的普得尼松治疗方案之间的无复发存活率.
主要方法:
- 追溯队列研究设计.
- 包括PNS患者在2年内进行了跟踪.
- 根据最初的普得尼松治疗持续时间 (8 vs. 12 周) 将患者分组.
主要成果:
- 两组之间第一次复发的时间没有显著差异 (p = 0.63).
- 2年后复发的相似累积发病率:75.6%用于标准治疗和72.9%用于延长治疗 (p = 0.79).
- 在标准和延长治疗组之间,超过2年的无复发存活率相当于标准和延长治疗组 (日志等级测试 = 0.51).
结论:
- 延长从8周到12周的原发性性综合征 (PNS) 治疗前尼松的时间,并没有显著改变2年后复发的累积发病率.
- 目前的证据表明,延长普得尼松治疗持续时间对减少PNS复发率没有益处.
- 可能需要进一步的研究来探索预防儿科性综合征复发的替代策略.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
217
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
217
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Psychosis: Goals of Pharmacotherapy
103
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
103
Adrenal Gland Disorders
1.3K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.3K
Inflammatory Bowel Disease IV: Pharmacological Management
111
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
111


